Background: Major complications following aesthetic breast surgery are uncommon and thus assessment of risk factors is challenging. Objectives: To determine the incidence and risk factors of major complications following aesthetic breast surgery and concomitant procedures. Methods: A prospective cohort of patients who enrolled into the CosmetAssure (Birmingham, AL) insurance program and underwent aesthetic breast surgery between 2008 and 2013 was identified. Major complications (requiring reoperation, readmission, or emergency room visit) within 30 days of surgery were recorded. Risk factors including age, smoking, body mass index (BMI), diabetes, type of surgical facility, and combined procedures were evaluated. Results: Among women, augmentation was the most common breast procedure (n = 41,651, 58.6%) followed by augmentation-mastopexy, mastopexy, and reduction. Overall, major complications occurred in 1.46% with hematoma (0.99%) and infection (0.25%) being most common. Augmentation-mastopexy had a higher risk of complications, particularly infection (relative risk [RR] 1.74, P < 0.01), than single breast procedures. Age was the only significant predictor for hematomas (RR 1.01, P < 0.01). Increasing age (RR 1.02, P = 0.03) and BMI (RR 1.09, P < 0.01) were risk factors for infection. Concomitant abdominoplasty was performed in 4162 (5.8%) female patients and was associated with increased risk of complications compared to breast procedures or abdominoplasty performed alone. Among men, correction of gynecomastia was the most common breast procedure (n = 1613, 64.6%) with a complication rate of 1.80% and smoking as a risk factor (RR 2.73, P = 0.03). Conclusions: Incidence of major complications after breast cosmetic surgical procedures is low. Risk factors for major complications include increasing age and BMI. Combining abdominoplasty with any breast procedure increases the risk of major complications.
mammaplasties, and 30,464 gynecomastia correction procedures.
Major postoperative complications after breast cosmetic surgery are rare. However, when such complications occur they frequently result in significant morbidity as well as in significant financial burden as often aesthetic surgical complications are not covered by the patient's health insurance in the United States.
As aesthetic breast surgery is becoming more common, there has been a rise in both combination cases involving breast procedures and male breast surgeries. Both of these categories remain an understudied niche of aesthetic breast surgery. Given these considerations and the high demand for aesthetic breast surgery, it is of utmost importance to identify the incidence and risk factors for complications to potentially minimize such adverse outcomes.
The most common early postoperative complications after breast surgery are hematoma and infection. [2] [3] [4] Complications are less frequent among patients who undergo breast augmentation for cosmetic reasons compared to reconstruction after mastectomy. 2 A review of elective non-reconstructive breast surgery from the National Surgical Quality Improvement Program (NSQIP) revealed low rates of complications in reduction mammaplasty, mastopexy, and augmentation-mammaplasty. The highest complication rate was seen in reduction mammaplasty. 4 A review of one year of CosmetAssure data revealed higher rates of complications in obese and diabetic patients undergoing breast augmentation. 3 There have only been small studies of gynecomastia correction that have evaluated mostly the effect of technique and presentation. 5 There is limited evidence on risks associated with combined procedures such as augmentation-mastopexy and combined breast-abdominoplasty. 6, 7 The primary aim of the current study was to determine the incidence of major postoperative complications after breast cosmetic surgical procedures and to identify risk factors associated with these complications using a large, prospective, multicenter database (CosmetAssure, Birmingham, AL). A secondary aim was to perform comparative analysis of postoperative complications among different types of breast cosmetic surgical procedures. Specifically, we examined whether performing multiple breast procedures (ie, augmentation-mastopexy) or combining with abdominoplasty increases the risk of major postoperative complications. Finally, we evaluated incidence and risk factors for complications after breast cosmetic procedures in men.
METHODS
The study population was comprised of a cohort of patients who were prospectively enrolled into the CosmetAssure insurance program and underwent cosmetic surgical 
Database
CosmetAssure is an insurance program that covers the costs of unexpected major complications from 24 covered cosmetic surgical procedures, which may not be reimbursed by the patient's primary health insurer. CosmetAssure was introduced in 2003 and has been collecting data on patient risk factors since 2008. This insurance program covers all 50 states in the United States. It is available to American Board of Plastic Surgery (ABPS)-certified plastic surgeons and is endorsed by the American Society of Plastic Surgeons (ASPS) and the American Society for Aesthetic Plastic Surgery (ASAPS). The program is also available to ASPS Candidates for Membership who have passed the ABPS Written Examination. Every patient undergoing any covered procedure at participating practices is required to enroll in the program. Patients are entered in the database prior to undergoing the operation or occurrence of complication, thus making it a prospective cohort. Surgeon-reported major complications, filed as claims, are recorded in the database. Personnel employed by CosmetAssure enter data provided by the surgeon at the time of patient enrollment, as well as any claims filed by the surgeon. CosmetAssure, being a private insurance company, has a vested interest in maintaining an accurate database for actuarial and audit purposes.
Major complications are defined as those occurring within 30 days of the operation and requiring hospital admission, emergency room visit, or a reoperation. This excludes complications that can be managed in clinic, such as minor wound infections and seromas, as they are not applicable for an insurance claim. The covered major complications include hematoma, infection, pulmonary dysfunction, cardiac complication, suspected or confirmed VTE (Venous Thromboembolism), myocardial infarction, and fluid overload. Other major complications (nerve injury, urinary retention etc.) have been reported to CosmetAssure but may not qualify for compensation. The database lists all procedures performed on the patient, making it possible to study specific individual procedures as well as procedure combinations (ie, patients undergoing multiple procedures under the same anesthetic.). The database also records demographic and comorbidity data including age, gender, body mass index (BMI), smoking, diabetes mellitus (DM), and type of surgical facility (accredited surgical centers [ASC], hospitals, and officebased surgical suites [OBSS] ).
Exposure
In this study cohort, exposure was defined as the type of cosmetic surgical procedure(s) performed. Breast surgery (augmentation, reduction, mastopexy, male breast surgery) was studied as the primary exposure, whether performed alone or in combination with face procedures (blepharoplasty, browlift, cheek implants, chin augmentation, facial resurfacing, hair replacement, otoplasty, rhinoplasty), body procedures (abdominoplasty, brachioplasty, buttock lift, calf implants, labioplasty, liposuction, lower body lift, thigh lift, upper body lift), and/or other breast procedures (augmentation-mastopexy) (Figure 1) .
In order to compare the risk of combined breast-abdominoplasty ("mommy makeover") with breast only procedures and abdominoplasty alone, the cohort of female patients undergoing only abdominoplasty was also analyzed.
Outcome
The primary outcome was occurrence of any major complication(s) (as defined above) within 30 days of the procedure. The secondary outcome studied was the type of complication. Since male patients form only a small fraction of this cohort, their outcomes are reported separately from female patients. Within the female cohort, outcomes are compared between breast only procedures and breast procedures combined with procedures on other body regions, as defined above.
Risk Factors
The potential risk factors evaluated included age, gender, body mass index, smoking, diabetes mellitus, type of facility, and combined procedures.
Statistical Analysis
Two separate, limited datasets were obtained from CosmetAssure, one with the enrollment data and the other with claims information. The enrollment dataset contained entries for each unique procedure. Thus, a patient undergoing combined procedures had separate entries for each procedure. A unique identifier was created using the following variables; date of birth, date of surgery, and BMI. Using this unique identifier, the enrollment dataset was restructured such that a patient undergoing combined procedures was counted once with each of the procedures listed as a separate variable. Another unique identifier was created with variables shared between the enrollment and claims datasets; date of birth, date of surgery, and gender. This identifier was then used to match the claims dataset to the restructured enrollment dataset. Of the 2506 patients in the claims dataset, 20 did not match to the enrollment data using the identifier. These cases were manually matched to enrollee's with the closest demographic characteristics. Kolmogorov-Smirnov statistic was used to check normal distribution of continuous variables; age and BMI. The only missing data were absent BMI information for 1046 (0.8%) patients. These patients were included in the analysis without replacing these missing data points. Patients with missing body mass index information were automatically excluded in regression analysis. Patient characteristics, risk factors, and complication rates between patients undergoing different procedure combinations were compared by two-tailed t test, Fisher exact test, or by Pearson chi-square tests. Separate analyses were performed on males and females. For purposes of univariate analyses, age and body mass index were recoded into ordinal variables with clinically appropriate categories. Standard logistic regression analysis was performed to identify the independent risk factors for postoperative complications. Dummy variables were created to compare the risk of combined abdominoplasty and breast surgery ("mommy makeover") with either procedure done alone. Outcomes were reported as 30-day incidence rates after the surgery. Unless otherwise noted, probability of type I error of less than 5% (P < 0.05) was used to determine statistical significance. All analyses were performed using IBM SPSS Statistics 23.0 software (IBM Corporation, Armonk, NY).
RESULTS

Dataset
Between May 2008 and May 2013, a total of 183,914 cosmetic surgical procedures were performed on 129,007 patients enrolled into the CosmetAssure program. Overall, the mean age was 40.9 ± 13.9 years (range, 5-93 years), BMI 24.3 ± 4.4 kg/m 2 (range, 17.0-56.3 kg/m 2 ), and the majority (93.5%) of patients were women (n = 120,650). Major complications occurred in 2506 patients (1.94% complication 
Demographics
Females
A total of 71,110 women underwent cosmetic breast procedures representing 58.9% of all female patients in the dataset. The mean age was 37.0 ± 11.9 years (range, 15-92 years) and BMI 23.0 ± 4.0 kg/m 2 (range, 17.2-54.0 kg/m 2 ). Among these, 10.0% were smokers, 1.2% had DM, and 23.3% were overweight or obese (BMI ≥ 25 kg/m 2 ). The majority of the procedures were performed in an ASC (61.3%) followed by hospitals (24.8%) and office-based surgical suites (13.9%). Seventy-nine percent (n = 56,447) of patients underwent only breast surgery and 14,663 (20.6%) had additional face and/or body procedures (Table 1) .
Males
A total of 2498 men underwent procedures on the breast, representing 29.9% of the male population in the dataset. The mean age was 31.3 ± 13.2 years (range, 12-79 years) and BMI 27.3 ± 4.6 kg/m 2 (range, 17.8-48.8 kg/m 2 ). Among these, 8.8% were smokers, 1.7% had diabetes, and 67.8% were overweight or obese. Similar to females, the majority of the procedures were performed in an ASC (59.2%) ( Table 1) . A greater proportion of male patients underwent combined procedures (26.0%) compared to women (20.6%). Overall, men represented 3.4% of all cosmetic breast procedures.
Types of Procedures
Females
Among women, 79.4% (n = 56,447) underwent only breast procedures. Breast augmentation was the most commonly performed breast procedure (n = 41,651, 58.6%) followed by augmentation-mastopexy (n = 8125, 11.4%), mastopexy alone (n = 3383, 4.8%), and reduction ammoplasty (3288, 4.6%). Patients undergoing augmentation or augmentation-mastopexy had lower mean age and BMI, lower prevalence of smoking, and higher prevalence of DM compared to patients undergoing mastopexy alone ( Table 2 ).
The remaining 20.6% (n = 14,663) of females underwent breast procedures combined with additional procedures on other body regions. Women undergoing additional procedures were older (mean age 41.1 ± 10.9 years), had higher BMI (mean BMI 25.1 ± 4.4 kg/m 2 ), and were more likely to undergo procedures at hospitals (30.6%). This patient population had more diabetics (1.7%) and fewer smokers (6.5%). Most commonly breast surgery was combined with body procedures (12,837 patients,18.1%, Table 3 ). Specifically, breast procedures were most frequently combined with liposuction and/or abdominoplasty. The specific combination of breast procedure and abdominoplasty ("mommy makeover") was performed in 4162 patients (5.8%) and this subset was analyzed separately.
Males
Among men, 74% (n = 1848) underwent only breast procedures. Gynecomastia correction was the most commonly performed breast surgery (n = 1613, 64.6%) followed by augmentation (n = 188, 7.5%). Similarly to females, breast procedures in men were most commonly combined with body procedures (24.4% of cases) with liposuction being the most common additional procedure.
Complications
Females
Of the 71,110 women undergoing breast surgery, 1313 (1.85%) developed at least one major complication. This compared favorably to the 1.94% incidence across all cosmetic procedures in the dataset. Hematoma was the most common complication, occurring in 1.05% (n = 746). This was followed by infection in 0.39% (n = 280), suspected VTE in 0.12% (n = 87), pulmonary dysfunction in 0.09% (n = 64), and confirmed VTE in 0.06% (n = 43) patients. Breast only procedures had a lower complication rate than combined procedures (1.46% vs 3.33%, P < 0.01). This statistically significant difference also held true for hematoma (0.99% vs 1.27%), infection (0.25% vs 0.94%), suspected VTE (0.06% vs 0.38%), pulmonary dysfunction (0.06% vs 0.21%), and confirmed VTE (0.009% vs 0.26%).
Breast Only Procedures. Among breast only procedures
(n = 56,447), augmentation (1.40%) or mastopexy (1.15%) had a lower complication rate than reduction (1.58%, P < 0.01) or augmentation-mastopexy (1.86%, P < 0.01). The distribution of individual complications between different breast procedures is shown in Table 4 . Only infection rate was found to have a statistically significant difference between various procedures.
Combined Procedures. Addition of a body (trunk or extremity) procedure to any breast procedure significantly increased the complication risk (3.54% vs 1.46%, P < 0.01). (Table 5 ). The difference was most pronounced in patients undergoing reduction mammaplasty with or without additional body procedures. (4.60% vs 1.58%) ( Table 3) . Combined breast and body procedures particularly had multiplefold higher incidence of confirmed VTE, suspected VTE, infection, pulmonary dysfunction (Table 5) .
Males
Of the 2498 men undergoing breast surgery, 59 (2.40%) developed at least one major complication. Hematoma was most common (1.76%) followed by suspected VTE (0.24%) and infection (0.16%).
Gynecomastia surgery performed alone had a complication rate of 1.80%. No complications occurred in other breast-only procedures in men. Combined gynecomastia and body procedures had a significantly higher incidence of complications (4.95%, P < 0.01).
Risk Factors of Complications
Females
We performed univariate and multivariate analysis to ascertain potential risk factors for complications in breast only procedures.
Age. Increasing age was associated with higher overall complication rate (Figure 2) . Specifically, the incidence of hematoma steadily increased from 0.26% in women younger than 20 years to 1.29% in those 60 year or older (P < 0.01). Infection incidence also increased from 0.30% to 0.46% (P = 0.01).
BMI. With increasing BMI there was a corresponding increase in complication rates (Figure 3 ), particularly infection. Obese patients had a 0.89% incidence of infection compared to 0.23% in those with BMI < 30 kg/m 2 (P < 0.01).
Smoking. There was no difference in complication rates among smokers and non-smokers (1.44% vs 1.46%, P = 0.9).
Diabetes. Diabetics had a higher incidence of infection than non-diabetics, though the difference was not statistically significant (0. 51% vs 0.25%, P = 0.19). This may be due to the very low prevalence of diabetes (1.0%) in this patient population. 
Males
Among men undergoing only breast procedures, smoking was the only factor associated with increased complications on univariate or multivariate analysis (RR 2.73, 95% CI 1.09-6.86). There was a trend towards a higher complication rate with increasing BMI, however it did not reach statistical significance. Hospitals had the lowest incidence of complications (0.63%) compared to OBSS (1.53%) or ASC (1.98%) though the association was not statistically significant (P = 0.14).
Complications in Breast Procedures Combined with Abdominoplasty
The risk factor profile and complications in women undergoing "mommy makeover" procedures (n = 4162), defined as any breast procedure performed in combination with abdominoplasty, was compared to those undergoing either breast procedures (n = 56,447) or abdominoplasty alone (n = 8621) ( Table 9 ). On univariate analysis, combined breast and abdominoplasty procedures had a statistically significant higher incidence of any major complication, hematoma, infection, and confirmed VTE compared to either procedure performed alone. The incidence of complications was higher for the corresponding combined procedure compared to augmentation (3.48% vs 1.40%), augmentation-mastopexy (4.50% vs 1.86%), mastopexy (3.96% vs 1.15%), and reduction (7.06% vs 1.58%). A similar observation was made when comparing the incidence of hematoma, infection, and confirmed VTE (Figure 4) .
Multivariate analysis demonstrated that isolated breast procedures or abdominoplasty had a lower risk of complications than combined procedures (Table 10) . Moreover, risk of hematoma was also lower in isolated breast procedures (RR 0.59, 95% CI 0.46-0.76) or abdominoplasty (RR 0.55, 95% CI 0.40-0.75) than combined procedures.
Infection (RR 0.31, 95% CI 0.22-0.44) and confirmed VTE (RR 0.03, 95% CI 0.01-0.09) were less likely after breast only procedures compared to combined procedures. Combined procedures did not have a statistically significant higher risk of infection or VTE compared to abdominoplasty alone. 
DISCUSSION
This study represents one of the largest investigations on major postoperative complications of breast cosmetic surgical procedures. Similar to published data, 1 our study demonstrated that aesthetic breast surgery accounts for the majority of cosmetic surgical procedures in the United States. By using a national, multicenter, prospective insurance database geared specifically to the complications of aesthetic surgery, we are not only able to perform robust analysis of the complications and their risk factors but also objectively address topics of age-old debates such as safety of combined augmentation-mastopexy or "mommy makeover" procedures. Previously reported complication rates of common aesthetic breast procedures have been similar to our series. 4, 5, [8] [9] [10] [11] [12] Within our review, postoperative hematoma was the most common complication. Despite being the most common major complication in breast surgery, there are no established risk factors for hematoma after major breast surgery. 13, 14 Our analysis demonstrated increasing age to be a statistically significant risk factor for hematoma. We did not find any significant difference in hematoma rate in different breast procedures.
In our series, rates of postoperative infection were low but represented the second most common complication. Post-operative infection was highest after breast reduction (0.55%), a procedure with historically high infection rates. A five-year review of NSQIP reduction mammaplasty cases revealed a higher infection rate (3.0%), 15 and rates of infection in breast reduction have been quoted as high as 7.3%. 16 A recent meta-analysis found increased age, obesity, diabetes, and American Society of Anesthesiologist (ASA) physical score of 3 or 4 to be risk factors for surgical site infection after major breast surgery. 17 There are mixed reports on the risk of infection with tobacco use and preoperative antibiotics. 17, 18 Smoking had a higher prevalence in female breast surgery compared to other cosmetic procedures, but we did not find smoking to be a risk factor for complications. Our database does not record small wound complications that are managed in the office, and therefore, minor wound complications in smokers may be under-reported in our review. We found obesity and age to be independent risk factors for infection. Local wound complications in obese patients have been well documented, and obesity being an independent risk factor for infection should not be surprising. On the other hand, advancing age being an independent risk factor for infection was an unexpected finding. The cosmetic breast surgery population is generally a young population, and age has not been established as a risk factor in cosmetic breast surgery. Shermak et al found age over 50 to be a risk factor for infection and poor wound healing in breast reductions. 19 One potential explanation may be age-related alterations in wound healing. There is evidence to suggest that older patients have delayed wound healing 20 and that declining levels of androgen and estrogen may delay wound healing. [21] [22] [23] Complication rates of individual breast procedures among women are low. Primary breast augmentation is the most common aesthetic surgery and is among the safer procedures reviewed in this study. Patients undergoing breast augmentation were younger, had lower BMIs, and were less likely to have diabetes compared to other breast procedures.
Reduction mammaplasty had a higher infection rate compared to other breast procedures. On average, patients undergoing breast reduction have a higher BMI compared to other breast surgeries and we found increasing BMI to be an independent predictor of infection. There is mixed literature on obesity in reduction mammaplasty. Wagner and Alfonso 24 and Roehl et al 25 did not find obesity to be a risk factor in breast reduction complications, but O'Grady et al 20 and Atterhem et al 26 found obesity to be a risk factor for wound complications. Unfortunately, our database did not include information on factors such as prophylactic antibiotic use and the amount of breast tissue removed which could play a role in postoperative infection. Since these were all "cosmetic reductions" not covered by patient's primary health insurance, the volume of tissue removed may have been less than a corresponding cohort of reductions covered by insurance. The American Association of Plastic Surgeons (AAPS) recently released a consensus statement recommending prophylactic antibiotics for clean breast surgery. 27 Given higher rates of infection in obese patients, the use of prophylactic antibiotics may especially be important in this group.
Mastopexy alone had the lowest complication rates of all breast procedures. Most of the literature on mastopexy has focused on techniques rather than complication rates. 12, 28 Like breast augmentation and breast reduction, obesity was associated with infections in mastopexy.
Outpatient plastic surgery in general has been shown to be safe with complication rates between 0.33% to 0.7%. 29 The American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF) provides accreditation of ambulatory settings including ASCs and OBSS and mandates safety protocols for these facilities. 30 Large reviews of accredited outpatient plastic surgery facilities have demonstrated the proven safety of these facilities for appropriately selected patients by board certified plastic surgeons. 30, 31 Our study demonstrated that breast surgery performed in an ASC or hospital had a relative risk of 1.34 for overall complications, compared to OBSS. These results are likely a representation of appropriate patient selection where patients who are deemed higher risk undergo their procedure(s) in more acute settings, including ASCs or hospitals.
Combining breast augmentation with mastopexy and its safety has been controversial since Dr Scott Spear's article "Augmentation/Mastopexy: 'Surgeon Beware.'" 32 Dr Spear warned that the complication risk was more than the summation of the complication rates of the individual procedures, and he supported this statement with a review of his own data on augmentation-mastopexy. 33 Our study demonstrates that augmentation-mastopexy had statistically significant higher incidence of complications, particularly infection (RR 1.74) than either procedure performed alone. Higher complication rates in augmentation-mastopexy have been demonstrated in the literature repeatedly. [33] [34] [35] In our data, older patients had higher rates of complications during augmentation-mastopexy, specifically hematoma. Despite higher complication rates, breast augmentation-mastopexy has a role in aesthetic breast surgery, but patient selection must be implemented properly in order to reduce the risk of complications.
There is a paucity of literature on the combination of aesthetic surgery procedures on different regions of the body. Cosmetic breast surgery is most commonly performed alone, but the interest in combining different aesthetic procedures is increasing. Our data demonstrated lower complication rates when cosmetic breast surgery is performed as a single region procedure, and more specifically adding a body procedure to breast surgery increased complication rates. Table 3 depicts the frequency and complication rates of different procedure combinations. The apparent inconsistency in the complications rates, such as augmentation, mastopexy, body and face combination having a complication rate (1.7%) half that of the mastopexy and body combination (3.43%) may be due to differences in sample size (118 vs 2972 patients) or may reflect a selection bias with the surgeons being more conservative in patient selection when offering multiple procedures.
Combining abdominoplasty with breast procedures, so called "mommy makeovers," is a common combination procedure. When performed alone, abdominoplasty carries a higher complication risk (3.03%) compared to breast surgery (1.46%). Our analysis showed a statistically significant increase in complication rates when breast procedures are added to abdominoplasty. This finding refutes multiple studies, mainly smaller retrospective reviews, which have found abdominoplasty does not add significant risk when combined with cosmetic breast surgery. 6,36-39 Saad et al found higher rates of venous thromboembolism in patients undergoing abdominoplasty and liposuction as well as abdominoplasty-hernia repair but not for abdominoplasty-breast procedures. 40 Previous reviews of NSQIP data have not reviewed combination cases, and our study represents the largest review of these cases. When examining specific complications, patients undergoing "makeover" procedures in our series were at higher risk of hematoma, compared to either procedure performed alone. "Makeover" procedures also carried increased risk of infection and VTE when compared to the corresponding breast-only procedure, but this was not significantly different from the risk inherent to abdominoplasty alone. Despite the increased risks of combination cases, it may not be feasible or practical to recommend separating surgeries into individual procedures. However, patients and physicians should be aware of the increased risk in this population.
Aesthetic male breast surgery is infrequent but represented a significant minority of aesthetic procedures among men (29.9%). The most common male breast surgery performed was correction of gynecomastia, which represented 64.6% of male breast surgical procedures. Despite a higher prevalence of diabetes and obesity in males, smoking was found to be the only independent risk factor for complications. This finding is interesting because no preoperative risk factors associated with complications following correction of gynecomastia have been reported so far. 41 Although smoking was found to be associated with complications in men, no such association was found among women. The reason for this finding is unclear and merits further investigation. Gynecomastia correction has a wide range of techniques, 42 which may contribute to complication risk but unfortunately, our database did not provide information on surgical techniques. Moreover, due to the small male cohort (n = 2498) the statistical analysis suffers due to a lack of power especially because of low incidence of complications.
The CosmetAssure insurance database is a powerful tool for assessment of clinical outcomes of cosmetic surgery. It provides prospectively collected data, which is necessary for determining true incidence of complications and risk factors. It is a multicenter database encompassing hospitals, ASCs, and OBSSs, making the results While the CosmetAssure database has many advantages, some of its limitations merit discussion. The BMI information was missing for 1046 (0.8%) patients in the database. We used BMI, along with date of surgery and date of birth, to create a unique identifier for restructuring the enrollment dataset. Multiple quality control measures were performed to confirm accuracy of restructuring. We manually looked at information on each patient who was missing BMI information from the unique identifier. There was no indication that more than one patient may have the same identifier due to this missing information. There was consistency in the type of facility and no duplication of the type of procedure. After linking the enrollment and claims datasets using another unique identifier, created with variables shared between the two datasets (date of birth, date of surgery, and gender), we manually checked the type of procedures between the two datasets for all 2506 complications. This again demonstrated accuracy of the restructuring and linking procedures. Excluding the 1046 patients with missing BMI information from analysis would have resulted in loss of valuable data on other variables. In terms of risk factor analysis, the regression model automatically excluded cases with missing data. It is possible that despite these considerations there may be errors in information on a few patients. The database fails to include minor, but clinically significant, complications (minor infection, wound breakdown, seroma etc.) since these are managed in the clinic and do not require hospitalization, emergency room visit, or reoperation. These complications are significantly more common than major complications, and important in cosmetic outcomes and patient perceived results. The database does not record certain major complications specific to breast surgery such as tissue necrosis and nipple loss. Moreover, the database does not register complications occurring after 30 days of the operation. Thus, it is not possible to report and/or compare outcomes such as capsular contracture, implant malposition and revisional breast surgery. The database does not differentiate between different techniques of a particular procedure which may predispose patients to certain complications. No information is available on measures such as ASA class, VTE prophylaxis, preoperative antibiotics, intraoperative temperature and blood pressure management, duration of surgery, patient's medications including antiplatelet or anticoagulant agents and thus their impact cannot be analyzed.
The database also lacks comprehensive information about patients' other comorbidities. Obesity is associated with multiple comorbid conditions such as coronary heart disease, hypertension, dyslipidemia, and fatty liver disease, which may contribute to surgical risk. However, assessment of available health conditions (diabetes, obesity, and smoking) suggest that the patient population seeking cosmetic surgery is significantly healthier compared to the general population of the United States, with low burden of comorbid conditions. Even though management of these major complications incur significant costs, it is possible that the plastic surgeon may write it off or be compensated by patient's primary health insurance provider. Either of these scenarios, though very unlikely, may lead to under-reporting of major complications to CosmetAssure. Finally, CosmetAssure is used by only a fraction of eligible plastic surgeons in the United States. A statistical limitation of using a cohort study design for examining risk factors in aesthetic surgery is that major complications are rare. Even with such a large cohort, infrequent complications such as cardiac events (0.03%) could not be comprehensively studied.
CONCLUSIONS
Aesthetic breast surgery represents the majority of cosmetic procedures performed in the United States. The incidence of major complications after aesthetic breast surgery is low. As expected, postoperative hematoma and infection are the most common complications. Age is the only statistically significant predictor for postoperative hematoma while increasing age and BMI are risk factors for infection. Breast augmentation-mastopexy has higher risk of complications, particularly infection, than single breast procedures. Concomitant abdominoplasty is associated with increased risk of complications than breast procedures or abdominoplasty alone. Among men, correction of gynecomastia is the most popular breast procedure with smoking as a statistically significant risk factor for complications.
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